Syneos Health Inc (SYNH) - Comprehensive Stock Analysis & Investment Research
Deep dive into Syneos Health Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Syneos Health Inc, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Syneos Health Inc: Syneos Health Inc operates in the Professional, Scientific, and Technical Services sector, establishing it as a mid-cap growth opportunity.
Syneos Health Inc (Stock Symbol: SYNH) is a leading company in the Professional, Scientific, and Technical Services sector , specifically operating within the Research and Development in Biotechnology industry.
The organization employs approximately 18607 professionals worldwide and operates under the strategic leadership of CEO Michael Bell.
The company has established itself as a growing mid-cap opportunity with strong fundamentals.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Syneos Health Inc's revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Syneos Health Inc: With $391M in annual revenue and 18.2% net margin, the company demonstrates exceptional profitability.
Annual Revenue: $391 million generating a 18.2% net profit margin .
Market Capitalization: $4457 million - Classified as a mid-cap growth stock with balanced risk-reward profile.
Return on Equity (ROE): 7.4% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Syneos Health Inc stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Syneos Health Inc: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Syneos Health Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Syneos Health Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Syneos Health Inc: Strong free cash flow generation demonstrates solid operational efficiency.
Syneos Health Inc strategically competes in the highly dynamic Research and Development in Biotechnology marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .
The company demonstrates robust operational efficiency through strong free cash flow generation of $325 million annually, complemented by impressive 33.6% year-over-year cash flow growth.
The company maintains a healthy 306.7% gross margin, indicating strong pricing power and operational efficiency.